THYBETAXOR
LIVE

Serial Number

79409214

Owner

Cascade Pharmaceuticals, Inc

Attorney

Eric Lamb

Filing Date

Oct 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

THYBETAXOR Trademark

Serial Number: 79409214 • Registration: 8054740

THYBETAXOR is a trademark filed by Cascade Pharmaceuticals, Inc on October 11, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Cascade Pharmaceuticals, Inc (6 trademarks)

Building 10,

Entity Type: 03

Trademark Details

Filing Date

October 11, 2024

Registration Date

December 9, 2025

Published for Opposition

October 21, 2025

Goods & Services

Medicines for human purposes for the treatment of inflammatory, metabolic, and immune system related diseases and disorders; diagnostic preparations for medical purposes; drugs for medical purposes, namely, pharmaceutical drug preparations for the prevention and treatment of inflammatory, metabolic, and immune system related diseases and disorders; bacteriological preparations for medical and veterinary use; biological tissue cultures for medical purposes; surgical implants comprised of living tissues; chemical preparations for medical purposes, being pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the immune system, digestive system, and metabolic system; opotherapy preparations; biological preparations for medical purposes, being pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the immune system, digestive system, and metabolic system; medicine cases, portable, filled in the nature of containers for medical use sold filled with a platelet additive solution; stem cells for medical purposes; chemical reagents for medical or veterinary purposes;

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jun 25, 2026 ADCH
FINAL DISPOSITION NOTICE SENT TO IB
Jun 21, 2026 FICS
FINAL DISPOSITION PROCESSED
Jun 21, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 30, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 13, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 13, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 9, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 9, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 9, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 21, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 15, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 22, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 22, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 22, 2025 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 25, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 25, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 25, 2025 COAR
REFUSAL PROCESSED BY IB
Jun 27, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 9, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 9, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 6, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 5, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 15, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 14, 2024 REPR